These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 32784218)

  • 1. Suboptimal prescribing behaviour associated with clinical software design features: a retrospective cohort study in English NHS primary care.
    MacKenna B; Curtis HJ; Walker AJ; Bacon S; Croker R; Goldacre B
    Br J Gen Pract; 2020 Sep; 70(698):e636-e643. PubMed ID: 32784218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinician impact and financial cost to the NHS of litigation over pregabalin: a cohort study in English primary care.
    Croker R; Smyth D; Walker AJ; Goldacre B
    BMJ Open; 2018 Jun; 8(6):e022416. PubMed ID: 29880577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lost cost savings to the NHS in England due to the delayed entry of multiple generic low-dose transdermal buprenorphine: a case scenario analysis.
    Chapman SR; Aladul MI; Fitzpatrick RW
    BMJ Open; 2019 Aug; 9(8):e026817. PubMed ID: 31375605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attitudes of Slovene general practitioners towards generic drug prescribing and comparison with international studies.
    Kersnik J; Peklar J
    J Clin Pharm Ther; 2006 Dec; 31(6):577-83. PubMed ID: 17176362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New mechanism to identify cost savings in English NHS prescribing: minimising 'price per unit', a cross-sectional study.
    Croker R; Walker AJ; Bacon S; Curtis HJ; French L; Goldacre B
    BMJ Open; 2018 Feb; 8(2):e019643. PubMed ID: 29439078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Electronic Health Record Interface Design on Unsafe Prescribing of Ciclosporin, Tacrolimus, and Diltiazem: Cohort Study in English National Health Service Primary Care.
    MacKenna B; Bacon S; Walker AJ; Curtis HJ; Croker R; Goldacre B
    J Med Internet Res; 2020 Oct; 22(10):e17003. PubMed ID: 33064085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends and variation in prescribing of low-priority treatments identified by NHS England: a cross-sectional study and interactive data tool in English primary care.
    Walker AJ; Curtis HJ; Bacon S; Croker R; Goldacre B
    J R Soc Med; 2018 Jun; 111(6):203-213. PubMed ID: 29787684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring the Impact of an Open Web-Based Prescribing Data Analysis Service on Clinical Practice: Cohort Study on NHS England Data.
    Walker AJ; Curtis HJ; Croker R; Bacon S; Goldacre B
    J Med Internet Res; 2019 Jan; 21(1):e10929. PubMed ID: 30664459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Has cost inhibited the uptake of more potent statins in England?
    Chapman SR; Fitzpatrick RW; Aladul MI
    Pharmacoepidemiol Drug Saf; 2017 Aug; 26(8):984-991. PubMed ID: 28612964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generic drug prices and policy in Australia: room for improvement? a comparative analysis with England.
    Mansfield SJ
    Aust Health Rev; 2014 Feb; 38(1):6-15. PubMed ID: 24480618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors Associated With Prescriptions for Branded Medications in the Medicare Part D Program.
    Socal MP; Bai G; Anderson GF
    JAMA Netw Open; 2021 Mar; 4(3):e210483. PubMed ID: 33651110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generic drug utilisation on the General Medical Services (GMS) scheme in 2001.
    Tilson L; McGowan B; Ryan M; Barry M
    Ir Med J; 2003 Jun; 96(6):176-9. PubMed ID: 12926759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low rate of generic prescribing in the Republic of Ireland compared to England and Northern Ireland: prescribers' concerns.
    McGettigan P; McManus J; O'Shea B; Chan R; Feely J
    Ir Med J; 1997; 90(4):146-7. PubMed ID: 9267094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do generics offer significant savings to the UK National Health Service?
    Kanavos P
    Curr Med Res Opin; 2007 Jan; 23(1):105-16. PubMed ID: 17257472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 10-year trends in English primary care glaucoma prescribing.
    Hogg HDJ; Connor A
    Eye (Lond); 2020 Jan; 34(1):192-196. PubMed ID: 31685974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of Potential Savings Through Therapeutic Substitution.
    Johansen ME; Richardson C
    JAMA Intern Med; 2016 Jun; 176(6):769-75. PubMed ID: 27159226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicaid prescription limits: policy trends and comparative impact on utilization.
    Lieberman DA; Polinski JM; Choudhry NK; Avorn J; Fischer MA
    BMC Health Serv Res; 2016 Jan; 16():15. PubMed ID: 26772962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do doctors in dispensing practices with a financial conflict of interest prescribe more expensive drugs? A cross-sectional analysis of English primary care prescribing data.
    Goldacre B; Reynolds C; Powell-Smith A; Walker AJ; Yates TA; Croker R; Smeeth L
    BMJ Open; 2019 Feb; 9(2):e026886. PubMed ID: 30813120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative evaluation of price and quality of some branded versus branded-generic medicines of the same manufacturer in India.
    Singal GL; Nanda A; Kotwani A
    Indian J Pharmacol; 2011 Apr; 43(2):131-6. PubMed ID: 21572645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicare Part D Payments for Topical Steroids: Rising Costs and Potential Savings.
    Song H; Adamson A; Mostaghimi A
    JAMA Dermatol; 2017 Aug; 153(8):755-759. PubMed ID: 28453645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.